Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, et al. J Am Coll Cardiol 2021;78:14-23.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, et al. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. J Am Coll Cardiol 2021;78:14-23.
PMID: 34210409